Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide Data.

Chon MW, Lee J, Chung S, Kim Y, Kim HW.

J Korean Med Sci. 2017 Oct;32(10):1694-1701. doi: 10.3346/jkms.2017.32.10.1694.

2.

Prescribing pattern of psychotropic medications in child psychiatric practice in a mental referral hospital in Botswana.

Olashore A, Ayugi J, Opondo P.

Pan Afr Med J. 2017 Feb 21;26:83. doi: 10.11604/pamj.2017.26.83.11212. eCollection 2017.

3.

Polypharmacy among children and adolescents with psychiatric disorders in a mental referral hospital in Botswana.

Olashore AA, Rukewe A.

BMC Psychiatry. 2017 May 10;17(1):174. doi: 10.1186/s12888-017-1347-6.

4.

Diagnostic profiles and predictors of treatment outcome among children and adolescents attending a national psychiatric hospital in Botswana.

Olashore AA, Frank-Hatitchki B, Ogunwobi O.

Child Adolesc Psychiatry Ment Health. 2017 Feb 10;11:8. doi: 10.1186/s13034-017-0144-9. eCollection 2017.

5.

Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid.

Hoagwood KE, Kelleher K, Zima BT, Perrin JM, Bilder S, Crystal S.

Health Aff (Millwood). 2016 Jul 1;35(7):1266-70. doi: 10.1377/hlthaff.2015.1423.

6.

Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.

Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG.

J Child Adolesc Psychopharmacol. 2017 Mar;27(2):117-124. doi: 10.1089/cap.2016.0040. Epub 2016 Jun 27.

PMID:
27348211
7.

Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial.

Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR Jr, Schneider J, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):469-78. doi: 10.1016/j.jaac.2016.03.014. Epub 2016 Apr 13.

8.

The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.

Baweja R, Belin PJ, Humphrey HH, Babocsai L, Pariseau ME, Waschbusch DA, Hoffman MT, Akinnusi OO, Haak JL, Pelham WE, Waxmonsky JG.

J Child Adolesc Psychopharmacol. 2016 Mar;26(2):154-63. doi: 10.1089/cap.2015.0053. Epub 2016 Jan 15.

9.

Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters.

Hamed AM, Kauer AJ, Stevens HE.

Front Psychiatry. 2015 Nov 26;6:168. doi: 10.3389/fpsyt.2015.00168. eCollection 2015. Review.

10.

Age and Cohort Patterns of Medical and Nonmedical Use of Controlled Medication Among Adolescents.

Austic E, McCabe SE, Stoddard SA, Ngo QE, Boyd C.

J Addict Med. 2015 Sep-Oct;9(5):376-82. doi: 10.1097/ADM.0000000000000142.

11.

Pediatric Bipolar Disorder: Subtype Trend and Impact of Behavioral Comorbidities.

Rajakannan T, Zito JM, Burcu M, Safer DJ.

J Clin Med. 2014 Mar 20;3(1):310-22. doi: 10.3390/jcm3010310.

12.

Mental Health Care Delivered to Younger and Older Adults by Office-Based Physicians Nationally.

Maust DT, Kales HC, Blow FC.

J Am Geriatr Soc. 2015 Jul;63(7):1364-72. doi: 10.1111/jgs.13494. Epub 2015 Jul 3.

13.

Rationale and Considerations for the Internet-Based Delivery of Parent-Child Interaction Therapy.

Comer JS, Furr JM, Cooper-Vince C, Madigan RJ, Chow C, Chan P, Idrobo F, Chase RM, McNeil CB, Eyberg SM.

Cogn Behav Pract. 2015 Aug 1;22(3):302-316.

14.

Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.

Vitiello B, Lazzaretto D, Yershova K, Abikoff H, Paykina N, McCracken JT, McGough JJ, Kollins SH, Greenhill LL, Wigal S, Wigal T, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 2015 Jul;54(7):550-6. doi: 10.1016/j.jaac.2015.04.004. Epub 2015 Apr 27.

15.

Point-of-Care Child Psychiatry Expertise: The Massachusetts Child Psychiatry Access Project.

Van Cleave J, Le TT, Perrin JM.

Pediatrics. 2015 May;135(5):834-41. doi: 10.1542/peds.2014-0720. Epub 2015 Apr 20.

16.

Evidence-based psychological treatments for mental disorders: modifiable barriers to access and possible solutions.

Harvey AG, Gumport NB.

Behav Res Ther. 2015 May;68:1-12. doi: 10.1016/j.brat.2015.02.004. Epub 2015 Feb 26.

17.

A prospective study of adolescents' nonmedical use of anxiolytic and sleep medication.

Boyd CJ, Austic E, Epstein-Ngo Q, Veliz PT, McCabe SE.

Psychol Addict Behav. 2015 Mar;29(1):184-91. doi: 10.1037/adb0000026. Epub 2014 Nov 24.

18.

Adverse effects of psychotropic medications in children: predictive factors.

Ninan A, Stewart SL, Theall LA, Katuwapitiya S, Kam C.

J Can Acad Child Adolesc Psychiatry. 2014 Sep;23(3):218-25.

19.

Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder.

Elkins RM, Carpenter AL, Pincus DB, Comer JS.

J Anxiety Disord. 2014 Dec;28(8):754-60. doi: 10.1016/j.janxdis.2014.09.003. Epub 2014 Sep 17.

20.

The diminished pipeline for medications to treat mental health and substance use disorders.

O'Brien PL, Thomas CP, Hodgkin D, Levit KR, Mark TL.

Psychiatr Serv. 2014 Dec 1;65(12):1433-8. doi: 10.1176/appi.ps.201400044. Epub 2014 Nov 17.

Supplemental Content

Support Center